ZBiotics raises $12m Series A for its ‘proudly GMO’ probiotics targeting gut health, hangovers and more
ZBiotics will expand its retail footprint as well as bring more use cases for its genetically engineered probiotics to market.
ZBiotics will expand its retail footprint as well as bring more use cases for its genetically engineered probiotics to market.
“It was probably around 2013 or 2014 when I was at Monsanto that it became really clear that CRISPR was going to matter” for plant breeding, says Pairwise cofounder and CEO Dr. Tom Adams.
50,000 petunia plants that glow in the dark are being made available direct to consumers in the US via Light Bio’s website at $29/plant.
The capital injection will also help advance work to develop Cavendish bananas engineered to resist the devastating fungal disease Fusarium wilt.
Spoiler alert: Hangover ‘cures’ don’t work, says Dr. Zack Abbott. If you overindulged last night, Gatorade won’t stop you feeling like death this morning. But a shot of ZBiotics just might…
French biotech startup Neoplants has come up with a novel approach to tackle a class of indoor air pollutants called volatile organic compounds.
Norfolk Plant Sciences has completed a pre-market consultation process with the FDA for its antioxidant-packed GM purple tomatoes.